Moderna coronavirus vaccine effort to get $483 million in federal funding [MarketWatch]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: MarketWatch
Moderna Inc. said late Thursday that it will receive up to $483 million from the U.S. government to accelerate development of a COVID-19 vaccine. Shares in Moderna rose 2% in the extended session. The Biomedical Advanced Research and Development Authority within the Department of Health and Human Services awarded the cash to accelerate the company's development of the mRNA-1273 vaccine candidate and fund it through U.S. Food and Drug Administration licensure. Moderna said that it plans to begin a Phase 2 study in the second quarter of 2020 and start Phase 3 testing as soon as the fall of 2020. The company said it plans to hire 150 new staff this year in the U.S. "By investing now in our manufacturing process scale-up to enable large scale production for pandemic response, we believe that we would be able to supply millions of doses per month in 2020 and with further investments, tens of millions per month in 2021, if the vaccine candidate is successful in the clinic," Moderna Chief Ex
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Is BioNTech SE (BNTX) A Good Stock To Buy Now? [Yahoo! Finance]Yahoo! Finance
- Moderna (MRNA) Climbs 16% as Arbutus-Genevant Legal Battle Clears [Yahoo! Finance]Yahoo! Finance
- The Sun Will Shine On Moderna Again - Initiating With A Buy [Seeking Alpha]Seeking Alpha
- Is Moderna Stock Outperforming the Dow? [Yahoo! Finance]Yahoo! Finance
- Why Moderna's $950M Patent Bill Is A Small Price For Pipeline Freedom [Seeking Alpha]Seeking Alpha
MRNA
Earnings
- 2/13/26 - Beat
MRNA
Sec Filings
- 3/5/26 - Form 8-K
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- MRNA's page on the SEC website